The latest news from oncology events around the world
Results from the multicentre, first-in-human phase 1 SERENA-1 trial (NCT03616587) presented at the 2024 San…
Dana-Farber Cancer Institute researchers (USA) are breaking new ground in the fight against systemic mastocytosis,…
According to two international studies presented at the ESMO Congress 2024, women who breastfeed after…
Treatment with a combination of haloperidol and lorazepam reduced symptoms of agitated delirium, a common…
Studies reported at ESMO 2024 have revealed new groups of women with early-stage (1) and…
A study on exercise for cancer patients, presented at ESMO 2024, draws on data from…
Data from SOLARIS (Alliance A021703), a multicenter double-blind phase III randomised clinical trial of vitamin…
Results from a clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) show a striking…
Trastuzumab deruxtecan shows substantial anti-cancer activity in brain metastases in patients with HER2-positive breast cancer…
Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359),…